Published by The Border Watch
THE tireless advocacy efforts of late lymphoedema sufferer Pam Moulden (pictured) has been recognised in both houses of parliament, with Health Minister
Stephen Wade and independent MP Troy Bell acknowledging her contribution.
After years of advocacy, South Australians living with lymphoedema now have access to subsidised compression garments to support the management of their condition.
Mr Wade told the state’s upper house of the leadership and tireless advocacy of Ms Moulden and Lymphoedema Support Group of South Australia president Monique Bareham in establishing the subsidy.
“It is people like Monique and Ms Moulden for whom this scheme is really dedicated,” he said.
“The legacy of their advocacy work will live on through the scheme.”
The State Government has committed almost $2.5m over the next two years to the scheme, with the Federal Government also contributing funding.
Until recently, South Australia was the only state without a government funding program to provide financial help with the cost of compression garments.
The Member for Mount Gambier acknowledged the efforts of Ms Moulden and Ms Bareham, as well as Mount Gambier woman Dulcie Hoggan.
“This was a real team effort, made possible by the continued advocacy of passionate people like Dulcie, Pam and Monique,” he said.
“Sadly, Pam passed away before this scheme was announced.
“However, her advocacy is now reflected in the thousands of South Australians able to access the scheme that will give a better life to those suffering from this condition.
“One of the most satisfying parts of being a local member is being able to represent your electorate, those who have a certain need and being able to speak out on their behalf and advocate in parliament for a change.”
The newly-established Lymphoedema Compression Garment Subsidy scheme will provide sustainable access to individuals to receive a full subsidy for up to two sets of garments every six months.
The scheme is being implemented across South Australia during 2020/21 through a staged roll out, with phase one starting with patients in the Limestone Coast and metropolitan Adelaide.